Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Mayo Clinic
Massachusetts General Hospital
Institut Cancerologie de l'Ouest
Royal Marsden NHS Foundation Trust
Tulane University
IDeA States Pediatric Clinical Trials Network
Indiana University
Masonic Cancer Center, University of Minnesota
BerGenBio ASA
Imperial College London
BioAegis Therapeutics Inc.
University of Oklahoma
Massachusetts General Hospital
Applied Biology, Inc.